Literature DB >> 19592075

Trifecta outcomes after robotic-assisted laparoscopic prostatectomy.

Sergey A Shikanov1, Kevin C Zorn, Gregory P Zagaja, Arieh L Shalhav.   

Abstract

OBJECTIVE: To evaluate the trifecta outcomes following robotic-assisted laparoscopic prostatectomy (RALP) and compare the results applying definitions of continence and potency as reported in the literature vs validated questionnaire. The trifecta rate of achieving continence, potency, and undetectable prostate-specific antigen (PSA) following radical prostatectomy has been estimated to be approximately 60% at 1-2 years in open radical prostatectomy series. The definitions of continence and potency were not standardized, which poses difficulty in comparing published results.
METHODS: A prospective, institutional RALP database was analyzed for preoperatively continent and potent men with >/= 1 year follow-up after bilateral nerve-sparing surgery. Continence and potency were evaluated preoperatively and at 3, 6, 12, and 24 months after surgery by surgeon interview (subjective) and using University of California Los-Angeles Prostate Cancer Index self-administered questionnaire (objective). Biochemical recurrence was defined as a detectable (> 0.05 ng/mL), increasing PSA on 2 consecutive tests.
RESULTS: Among 1362 consecutive RALPs, 380 patients were preoperatively potent and continent underwent surgery with bilateral nerve-sparing technique and had sufficient follow-up. Trifecta rates applying subjective continence and potency definitions were 34%, 52%, 71%, and 76% at 3, 6, 12, and 24 months, respectively. The corresponding trifecta rates using objective continence and potency definitions stood at 16%, 31%, 44%, and 44%. The difference was statistically significant at each time point (P < .0001).
CONCLUSIONS: RALP provides trifecta outcome rates comparable to open surgery. The outcome rates vary significantly depending on the tools used for continence and potency evaluation.

Entities:  

Mesh:

Year:  2009        PMID: 19592075     DOI: 10.1016/j.urology.2009.02.082

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

1.  HIFU: Definitely ready for prime time.

Authors:  Jack Barkin
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 2.  Contemporary outcomes of focal therapy in prostate cancer: what do we know so far...

Authors:  John F Ward
Journal:  World J Urol       Date:  2010-08-03       Impact factor: 4.226

3.  Technical advances in robot-assisted laparoscopic radical prostatectomy.

Authors:  Ryan Turpen; Hany Atalah; Li-Ming Su
Journal:  Ther Adv Urol       Date:  2009-12

Review 4.  Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.

Authors:  Lei Wang; Baojun Wang; Qing Ai; Yu Zhang; Xiangjun Lv; Hongzhao Li; Xin Ma; Xu Zhang
Journal:  Int Urol Nephrol       Date:  2017-02-25       Impact factor: 2.370

5.  Multiparametric MRI maps for detection and grading of dominant prostate tumors.

Authors:  Mehdi Moradi; Septimiu E Salcudean; Silvia D Chang; Edward C Jones; Nicholas Buchan; Rowan G Casey; S Larry Goldenberg; Piotr Kozlowski
Journal:  J Magn Reson Imaging       Date:  2012-01-20       Impact factor: 4.813

Review 6.  Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities.

Authors:  Thiago Fernandes Negris Lima; Joshua Bitran; Fabio Stefano Frech; Ranjith Ramasamy
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

7.  Oncologic results, functional outcomes, and complication rates of robotic-assisted radical prostatectomy: multicenter experience in Turkey including 1,499 patients.

Authors:  A I Tasci; I Tufek; E Gumus; A E Canda; V Tugcu; F Atug; U Boylu; Z Akbulut; S Sahin; A Simsek; A R Kural
Journal:  World J Urol       Date:  2014-09-13       Impact factor: 4.226

Review 8.  Does robotic prostatectomy meet its promise in the management of prostate cancer?

Authors:  Kuo-How Huang; Stacey C Carter; Jim C Hu
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 9.  Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?

Authors:  Catherine E Lovegrove; Vincenzo Ficarra; Francesco Montorsi; James N'Dow; Andrea Salonia; Suks Minhas
Journal:  Int J Impot Res       Date:  2019-12-13       Impact factor: 2.896

10.  Oncological outcomes following robotic-assisted radical prostatectomy in a multiracial Asian population.

Authors:  Low Wei Xiang Alvin; Sim Hong Gee; Huang Hong Hong; Cheng Wai Sam Christopher; Ho Sien Sun Henry; Lau Kam On Weber; Tan Puay Hoon; Lee Lui Shiong
Journal:  J Robot Surg       Date:  2015-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.